In the News

Connect with us

Stay Informed.
Get the latest news and updates on MSK’s cancer care and research breakthroughs sent straight to your inbox with our e-newsletters.
Newsletter Sign Up
201 News Items found
Dana Pe'er
AACR: How Cellular Plasticity Drives Cancer Metastasis

In a plenary presentation at the 2024 American Association for Cancer Research (AACR) Annual Meeting, Dr. Dana Pe’er highlighted three recent research collaborations between her lab and other labs at MSK that have shed new light on the ability of cancer cells to adapt and spread.
Gloved hands hold a pipette over two bottles of pink solution.
Finding
The Gut Microbiome and Cancer: MSK Researchers Present New Findings

Research led by Josie Robertson Investigator Karuna Ganesh provided clues that microbiomes might explain the increase in colorectal cancer among younger patients.
MSK scientist Britta Weigelt and MSK physician-scientist Sarah Kim
New Progress Using Liquid Biopsies to Analyze cfDNA for Endometrial and Cervical Cancers

Learn how MSK’s liquid biopsy test, MSK-ACCESS, could improve the lives of patients with gynecologic cancers.
MSK medical oncologist Luis Diaz, Jr.
In the Clinic
The Science Behind the FDA’s Approval of an Immunotherapy for Mismatch Repair–Deficient Cancers

A new paper from MSK physician-scientist Luis Diaz presents the evidence on which the FDA approved the immunotherapy drug pembrolizumab for cancers with a specific genetic abnormality.
Two female healthcare professionals performing a mammogram on a patient
In the Clinic
For Less Familiar Gene Mutations Linked to Breast Cancer, Research Aims to Create Screening Guidelines

Computer models suggest breast cancer screening guidelines for people with mutations in the genes ATM, CHEK2, and PALB2.
MSK physician scientist Piro Lito, MD, PhD
Q&A
A Potential Advance Against RAS Gene-Driven Cancers

Learn about insights that could lead to a new class of drugs against cancers caused by RAS gene mutations.
Colorectal Surgeon Dr. Julio Garcia-Aguilar seen in exam room with Nurse Kieran Kelleher
Why Watch and Wait Instead of Rectal Cancer Surgery May Be Right for You

Learn how MSK uses the watch-and-wait approach to rectal cancer, which can preserve people's quality of life by successfully treating rectal cancer without removing the rectum.
MSK Kids patient Irene Dimatulac
Cancer Straight Talk: How MSK Supports Young Adults with Cancer

Learn how the Lisa and Scott Stuart Center for Adolescent and Young Adult Cancers at Memorial Sloan Kettering is transforming the experience, care, and outcomes of teens and young adults with cancer.
Michael Berger, PhD, Co-Director of the Marie-Josée and Henry R. Kravis Center for Molecular Oncology and Elizabeth and Felix Rohatyn Chair for Junior Faculty
Exposing a Cancer Cell’s Weakness

MSK has developed an arsenal of tests that are at the front lines of precision treatments. They target the structure of proteins that cause cancer, offering people new hope.
Dr. Andrew Vickers
Feature
The Truth About PSA Tests and Prostate Cancer Screening 

PSA testing is an important part of screening for prostate cancer, when it’s used the right way. Learn the truth dispelling seven myths about the PSA test.